The Sperminator
May 24, 2017
Biohybrid micromotor drug delivery for gynecological cancers
1 min read

May 24, 2017
Biohybrid micromotor drug delivery for gynecological cancers
1 min read
May 18, 2017
What’s the difference between a bacterium and a nanorobot?
1 min read
May 18, 2017
The extended release oral dosage form developed by Gio Traverso and colleagues has the potential to vastly improve drug delivery and compliance; but how easy will it be to bring to market?
1 min read
May 18, 2017
How controlled release can lead to better compliance
1 min read
May 18, 2017
Nominations are now open for The Medicine Maker 2017 Innovation Awards
1 min read
May 18, 2017
What will medicine look like in 2050? Bertalan Mesko’s job is all about looking at which technologies could transform our lives – and healthcare.
1 min read
May 17, 2017
Given pharma’s new reality of niche products and diversified pipelines, flexibility is key – and modular technologies can go a long way to easing capacity dilemmas.
1 min read
May 17, 2017
Disposable technologies are expected to see even greater demand in the future – and that puts pressure on suppliers to up their game in terms of lead times.Disposable technologies are expected to see even greater demand in the future – and that puts pressure on suppliers to up their game in terms of lead times.
1 min read
May 17, 2017
Hot-melt coating may require vast process knowledge and formulation expertise, but when the outcome is reduced processing times and costs, who cares?
1 min read
May 17, 2017
Over the past four decades, John Lambert has spent most of his time either on the water or in the lab. Today, Lambert is Executive VP Emeritus & Distinguished Research Fellow at ImmunoGen, and a Director of the Head Of The Charles Regatta. Here, he talks antibody-drug conjugates and his involvement with Kadcyla.
1 min read
False
False